Company Info
| Phone: | (972) 904-2029 |
| Year Established: | 1998 |
Contacts
| Primary: | Calvin Wallen III President & Chairman |
| Other: | Elvia Gustavson Head of Regulatory Affairs Warren Sherman, MD CMO Robert Schleizer CFO |
Company Description
Venturis Therapeutics, formerly CardioVascular Bio, is a biopharmaceutical company developing protein drug candidates to address diseases such as severe coronary heart disease, diabetic wounds, peripheral artery disease, erectile dysfunction, stroke, and spinal disk disease.
